.jpg)
15 hours ago
4
Article content
- Asia-Pacific market represents around 60% of global cylindrical Li-ion demand [1]
- HPQ holds a 36.8% equity interest in Novacium SAS and an exclusive North American license to Novacium technologies for Canada, the United States, and Mexico and sell GEN4 cells under its ENDURA+ trademark.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
MONTREAL, May 21, 2026 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company specializing in advanced materials and next-generation processes, today announced that its French technology partner, Novacium SAS, has signed a Letter of Intent (“LOI”) with GH Technologies Co., Ltd. (“GH Technologies”) [2]. The arms-length LOI was signed on May 15, 2026, at the 18th China International Battery Fair (“CIBF”) and covers the supply of Novacium’s GEN4 lithium-ion cells in 18650 and 21700 formats, along with other lithium-ion batteries built on Novacium’s GEN4 silicon anode technology.
Article content
Article content
Article content
Article content
Article content
Article content
Dr.
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
Jed Kraiem
Article content
, Chief Operating Officer of Novacium,
Article content
Article content
and Mr.
Article content
Jacques Shen
Article content
, CEO of GH Technologies Co., Ltd., at CIBF 2026.
Article content
The non-binding, non-exclusive LOI establishes a 36-month framework for commercial prospecting and potential distribution across multi-sector applications, including light electric mobility, embedded systems, and high-energy-density electronic equipment in Asia-Pacific, a region that accounts for more than 57% of global demand for cylindrical lithium-ion cells [1]. A key objective of the LOI is to evaluate potential commercial opportunities for Novacium GEN4 products in Asia-Pacific markets over the term of the agreement.
Article content
“Following an extensive evaluation of NOVACIUM GEN4 cells, including reported capacity exceeding 6,600 mAh, reported energy density of 319.9 Wh/kg, and international certifications including IEC 62133, UL 1642, and UN 38.3,
[3] GH Technologies agreed to enter into this LOI with Novacium to further evaluate potential business opportunities in Asia-Pacific markets,” stated Mr. Jacques Shen, CEO of GH Technologies Co., Ltd.
Article content
Article content
The completion of a definitive transaction remains subject to the negotiation and execution of a purchase and sale agreement, the successful technical validation of the cells by GH Technologies Co., Ltd.’s customers within their targeted applications, and the receipt of all applicable regulatory approvals.
Article content
“The signing of this LOI at CIBF supports Novacium’s ongoing efforts to evaluate potential commercial opportunities for its GEN4 battery technologies in Asia,” said Dr. Jed Kraiem, Chief Operating Officer of Novacium SAS. “The discussions with GH Technologies reflect interest in evaluating GEN4 cells for applications requiring high-capacity lithium-ion solutions.”
Article content
“This LOI provides a framework for Novacium and GH Technologies to evaluate potential business opportunities involving GEN4 battery technologies in Asia-Pacific markets,” said Bernard Tourillon, Chairman and Chief Executive Officer of HPQ Silicon Inc. “HPQ’s 36.8% equity ownership in Novacium SAS and its exclusive North American license provide the Company with access to these technologies for Canada, the United States, and Mexico under the HPQ ENDURA+ trademark.”
English (US)